Stem Cell Treatments & Stem Cell Therapy
call now
              
menu

Stem Cell Gene Therapy to Revolutionize Medicine

Find out if you are a candidate for Stem Cell Clinical Studies Below

  • Stem Cell Therapy Patient Studies!
  • Stem Cell Basics
stem-cell-gene-therapy

Stem cells and regenerative medicine are revolutionizing and improving the medical arena on many fronts. With the use of stem cell therapy victims of incurable and lethal diseases, such as AIDS and Leukemia, are experiencing a decrease in symptoms, in some cases complete remission, and as a result restoring the quality of their lives. The latest research in stem cell therapy is gene therapy, a process in which stem cells are being engineered and delivered to help the body properly function.

PH93428-a.jpg

Neurodegenerative disorders such as Parkinson's and amyotrophic lateral sclerosis (ALS) have been considered life threatening diseases that have many different underlying causes which diminish the quality of life. However, according to Jason Williams, M.D., founder and CEO of Neuralgene, a start up biotech company for AAV gene therapy, the process of gene therapy may have found a way to reduce and prevent the re-occurrence of Neurodegenerative disorder symptoms. Dr. Williams said "This is a completely new therapy for ALS, and the groundwork for this technology will lead to the treatment of many other diseases."

Throughout his extensive stem cell based scientific research, Dr. Williams has discovered a new way to treat victims of neural-degenerative diseases that my have long-lasting effects. It all started when he found that the production of Factor H by fat-derived mesenchymal stem cells may be a key to activity and the production of proteins that inhibit the attack of ALS. As Dr. Williams began to develop gene therapy he targeted neural growth factors, and a protein, TDP-43, that inhibits ALS. As a result, what is known as the AAV9 viral vector delivers and distributes neural growth factors, TDP-43 protein and multiple genes including the Factor H, to the malfunctioning neural cells. Animal studies have since demonstrated the safety of this gene therapy platform.

PH93428-b.jpg

His development today focuses on gene delivery to the brain and spinal cord with genetically engineered stem cells. Dr. Williams was quoted saying "Our gene therapy will target several of the main underlying mechanisms related to ALS with the hopes of getting a good response in a larger group of patients. However, our platform is versatile, allowing us to change and add different target genes. We expect that soon we will be able to perform a detailed genetic analysis of the patient, identifying their exact underlying cause of ALS. Then we will be able to tailor the therapy to each individual patient."

To read the original press release of this story please click here.


facebook Email Google Plus LinkedIn Pinterest Skype YouTube

About Us | Site Map | Contact Us


1200 Prospect St.
La Jolla, CA 92037

The stem cell studies described on this website have been designed by StemGenex® to be overseen by an Institutional Review Board (IRB) in full compliance with all applicable regulations and standards. Those who access this web site should consult their Physician before following any of the suggestions or making any conclusions from the web site.

StemGenex® provides information regarding : Stem Cell Research | Stem Cell Doctors | Stem Cell Therapy

Copyright ©2013 StemGenex®. All rights reserved. StemGenex®, the StemGenex® logo, and ‘The Human Repair Kit’ are trademarks of StemGenex®.

Privacy Policy and our Terms & Conditions Disclaimer.

StemGenex Inc BBB Business Review Cell Therapy